Does Bowel Preparation Alter Diagnostic Yield in Capsule Endoscopy?

Not Applicable

Completed

• Conditions: Obscure gastrointestinal bleeding; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12614000883617
• Lead Sponsor: Royal Brisbane and Women's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-20
• Study Completion: 2019-11-29
• Last Update Posted: 28 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 237

Inclusion Criteria

* All participants must be over 18 years of age
* Able to give informed consent to trial participation
* OGIB without a cause being found on gastroscopy and colonoscopy

Exclusion Criteria

* Medical contraindication to outpatient PEG-based preparation solution
* Chronic Kidney Disease Stage 5
* Heart failure – NYHA class 4
* Fluid restricted to <2L/day
* Currently pregnant or attempting pregnancy
* PEG Allergy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. To determine if preparation regimes alter detection rates of relevant abnormal findings as assessed by an expert reader of the CE imaging and analysis of the results for each patient per lesion. <br>(Examples of relevant abnormal findings include angioectasias/angiodysplasias, ulcerations, arteriovenous malformations, varices, presence of active bleeding, multiple (>3) erosions and diverticulae.)<br>[At the time of CE reading/reporting ideally within 21 days of the procedure<br>]